Autonomix Medical Inc. Co... (AMIX)
NASDAQ: AMIX
· Real-Time Price · USD
1.13
-0.03 (-2.59%)
At close: Sep 12, 2025, 11:44 AM
Company Description
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.
Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
The company was incorporated in 2014 and is based in The Woodlands, Texas.
Autonomix Medical Inc. Common Stock
| Country | United States |
| IPO Date | Jan 29, 2024 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Bradley Hauser |
Contact Details
Address: 21 Waterway Avenue The Woodlands, United States | |
| Website | https://autonomix.com |
Stock Details
| Ticker Symbol | AMIX |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001617867 |
| CUSIP Number | 05330T106 |
| ISIN Number | US05330T2050 |
| Employer ID | 47-1607810 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Bradley Hauser | Chief Executive Officer & President |
| Landy Toth | Co-Founder & Chief Technology Officer |
| Trent N. Smith CPA | Chief Financial Officer |
| Dr. Robert Schwartz M.D. | Co-Founder & Chief Medical Officer |
| Jennifer Cook | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 11, 2025 | 424B3 | Filing |
| Sep 03, 2025 | S-1/A | [Amend] Filing |
| Aug 29, 2025 | PRE 14A | Filing |
| Aug 27, 2025 | 8-K | Current Report |
| Aug 26, 2025 | 8-K | Current Report |
| Aug 25, 2025 | 424B5 | Filing |
| Aug 20, 2025 | S-1 | Filing |
| Aug 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Aug 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Aug 13, 2025 | 4 | Filing |